Stock Yearly Return 2019
Start date: 12/31/2018
End date: 12/31/2019
Start price/share: $123.96
End price/share: $149.28
Dividends collected/share: $0.00
Total return: 20.43%
Average Annual Total Return: 20.43%
Starting investment: $10,000.00
Ending investment: $12,043.00
Years: 1.00


JAZZ average annual return is presented with the assumption of reinvestments of any dividends on ex-date.
Compare JAZZ average annual return versus benchmarks:

S&P Average Annual Return
Dow Average Annual Return
Nasdaq 100 Average Annual Return
Russell 2000 Average Annual Return
Gold Average Annual Return
10 Year Treasury Average Annual Return
Growth of $10,000.00
Without Dividends Reinvested Into JAZZ


Also see:
JAZZ stock yearly return 2020
JAZZ YTD return
JAZZ average annual return 10 years
Jazz Pharmaceuticals is a biopharmaceutical company. Co.'s products are: Xyrem®, which is for the treatment of both cataplexy and excessive daytime sleepiness (EDS), in both adult and pediatric patients with narcolepsy; Sunosi®, which improves wakefulness in adult patients with EDS associated with narcolepsy or obstructive sleep apnea; Defitelio®, which treats adult and pediatric patients with hepatic veno-occlusive disease; Erwinaze®, which is a treatment for patients with acute lymphoblastic leukemia; and Vyxeos®, which is a product for the treatment of adults with newly-diagnosed therapy-related acute myeloid leukemia or acute myeloid leukemia with myelodysplasia-related changes. The JAZZ stock yearly return is shown above.

The yearly return on the JAZZ stock yearly return page and across the coverage universe of our site, is a measure of the annual return over the calendar year 2019 for the given stock. When performing this calculation it is important to factor in dividends, because a financial instrument's annual return is more than just the change in price if that instrument pays a dividend or coupon.

One way to factor dividends into the return is simply to count them as cash — we don't do that here. Instead, our website aims to empower investors by performing the JAZZ annual return calculation with any dividends reinvested as applicable (on ex-dates).
Quotes delayed 20 minutes
Get Free SEC filing alerts for JAZZ:
JAZZ SEC Filing Email Alerts ServiceExternal link
10 Most Oversold Stocks in the S&P
10 Most Overbought Stocks in the S&P
10 ETFs With Stocks That Insiders Are Buying
10 ETFs With Most Upside To Analyst Targets
The DividendRank Top 25
Warren Buffett Dividend Stocks
10 Cheap Dividend Stocks Under $10
10 Energy Stocks You Can Buy Cheaper Than Insiders Did
10 Top DividendRank'ed Energy Stocks
The 10 Highest Yielding Preferred Stocks
The 10 Highest Yielding Preferred Stocks
The 15 Most Active Call & Put Options of the S&P 500 Components
Video: Don't Forget Dividends in Average Annual Return!


If the video does not load after a few moments, Upgrade to the Latest Flash Player.
Jazz Pharmaceuticals (JAZZ) is categorized under the Healthcare sector; to help you further research average annual return performance across stocks, below are some other companies in the same sector:

JNCE Average Annual Return
JNJ Average Annual Return
JNP Average Annual Return
KALA Average Annual Return
KALV Average Annual Return
KBLM Average Annual Return
KDMN Average Annual Return
KEQU Average Annual Return
KERX Average Annual Return
KIDS Average Annual Return
More Healthcare companies »

 

JAZZ Stock Yearly Return 2019 | www.AverageAnnualReturn.com | Copyright © 2021 - 2021, All Rights Reserved

Nothing in AverageAnnualReturn.com is intended to be investment advice, nor does it represent the opinion of, counsel from, or recommendations by BNK Invest Inc. or any of its affiliates, subsidiaries or partners. None of the information contained herein constitutes a recommendation that any particular security, portfolio, transaction, or investment strategy is suitable for any specific person. All viewers agree that under no circumstances will BNK Invest, Inc,. its subsidiaries, partners, officers, employees, affiliates, or agents be held liable for any loss or damage caused by your reliance on information obtained. By visiting, using or viewing this site, you agree to the following Full Disclaimer & Terms of Use and Privacy Policy. Video widget and market videos powered by Market News Video. Quote and option data delayed at least 15 minutes; stock quote data powered by Ticker Technologies, and Mergent.